Advocating for Australia’s life sciences. The sector solving the world’s most complex health problems and powering Australia’s economic growth.
We represent Australia's entire life sciences ecosystem from early-stage discovery to translation, development, commercialisation, manufacturing, and global trade.
With a national voice and a growing membership community built on collaboration, we advocate, shape policy, and connect Australian innovators to industry partners, investors and global markets.
Our vision is for Australia to be a global leader in developing and commercialising innovative life science companies.
Employs 1 in every 60 jobs in Australia
2,900 Australian life sciences organisations
Over 1,600 biotech and medtech companies
Together, our members power the full lifecycle of health innovation in Australia — from research discovery to translation, clinical trials, development, manufacturing, commercialisation and global trade.
Join our membership community and connect with Australia’s thriving life sciences ecosystem.
Join us on the Gold Coast this October for Australia’s Biggest Week in Biotech, which brings the full strength of the life sciences ecosystem together in one dynamic, high-impact week with our flagship events — AusBiotech International Conference and AusMedtech Conference, alongside AusBiotech Invest.
Join us in Sydney on 30 July and catch up with friends and colleagues, share ideas, build relationships and make new contacts in the vibrant NSW biotechnology community.
Register
Australia’s leading life sciences investment event, part of Australia’s Biggest Week in Biotech.
Australia’s largest life sciences conference part of the Australia’s Biggest Week in Biotech.
AusBiotech has announced that Australia's Biggest Week in Biotech 2027 will be held in Brisbane from 23–27 August, marking a shift from its traditional October timing.
More than three quarters of Australia’s biotech, medtech and health tech companies recently surveyed said they will be significantly or moderately negatively impacted by the proposed Budget changes to the RDTI.
Proposed Budget changes to the Research and Development Tax Incentive (RDTI) will disproportionally impact Australia’s biotech, medtech and health tech sector forcing more home-grown companies to consider moving overseas.
Connect with leaders, shape the future of the sector, and access the relationships and insights that help organisations grow.